News-Tongling Bionics

全部

全部
产品管理
新闻资讯
介绍内容
企业网点
常见问题
企业视频
企业图册

-

NEWS

A Race Against Death: How Zhejiang University Hospital's Cardiovascular Center Saved a Critical Heart Failure Patient with Tongling Lifescience's Televad P50

2025-01-04

Heart failure, the end-stage progression of cardiovascular diseases, is notorious for its high morbidity and mortality rates—often deemed the "final battlefield" in cardiology. While traditional drug therapies offer symptomatic relief, and heart transplants face donor shortages, a groundbreaking solution has emerged in recent years: the percutaneous ventricular assist device (pVAD), a safer and more effective treatment that brings new hope to patients.

Breaking News! Tongling Bionic Forges Strategic Partnership with Transvascular Implant Instrument Research Institute

2024-12-19

On the morning of December 18, the Transvascular Implant Instrument Research Institute (hereinafter referred to as the "Institute") was inaugurated in Binjiang District, Hangzhou, affiliated with the Second Affiliated Zhejiang University School of Medicine. This milestone marks the establishment of China's first innovation platform dedicated to high-end transvascular implantable Instruments.

Clinical Applications of Non-Invasive Cardiac Output Monitors

2024-11-07

Hemodynamic factors are closely linked to the development, progression, and treatment of cardiovascular and cerebrovascular diseases.

Tongling Bionic Honored as National "Little Giant" Enterprise by MIIT

2024-09-10

Recently, the Ministry of Industry and Information Technology (MIIT) announced the sixth batch of specialized and sophisticated "Little Giant" enterprises, with Anhui Tongling Bionic Technology Ltd. being recognized. This prestigious accreditation reaffirms the company's strong technological capabilities and tremendous growth potential.

< 1 2 >

Anhui Tongling Bionic Technology Co., Ltd.

Tel: 400 636 3262
E-mail: BD@telelife.com.cn

Add.: Building A7, National Health Big Data Industrial Park,

Hefei High-tech Zone, Anhui, China

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

required

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

analyze

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

Feature

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

advertise

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.

WeChat

Anhui Tongling Bionic Technology Co., Ltd.

Tel: 400 636 3262
E-mail: BD@telelife.com.cn

Add.: Building A7, National Health Big Data Industrial Park, Hefei High-tech Zone, Anhui, China

WeChat

皖网药信备字〔2025〕00115号

Privacy Notice

-

NEWS

COOKIES

COOKIES

Sorry，当前栏目暂无内容!

Sorry，The current column has no content!